[Bronchial asthma: intractable factors and treatment of asthma].
Sagara
H
H
Department of Medicine and Clinical Immunology, Dokkyo University School of Medicine.
Makino
S
S
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001249:Asthma / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D016535:Bronchial Hyperreactivity; D016084:Bronchoconstriction; D002908:Chronic Disease; D016207:Cytokines / Q000378:metabolism / Q000502:physiology; D006801:Humans; D006969:Hypersensitivity, Immediate; D007073:Immunoglobulin E / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism; D013315:Stress, Psychological
D000318:Adrenergic beta-Agonists; D016207:Cytokines; D007073:Immunoglobulin E